- CA$54.17m
- CA$68.28m
- CA$93.59m
- 57
- 79
- 64
- 74
Annual income statement for Imaflex, fiscal year end - December 31st, CAD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 81.1 | 86.7 | 107 | 112 | 93.6 |
Cost of Revenue | |||||
Gross Profit | 11 | 16.6 | 17.4 | 18 | 11 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Total Operating Expenses | 77.2 | 77.3 | 97 | 101 | 90.6 |
Operating Profit | 3.91 | 9.42 | 10.5 | 10 | 2.97 |
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 2.21 | 8.21 | 9.8 | 11 | 0.813 |
Provision for Income Taxes | |||||
Net Income After Taxes | 1.54 | 6.35 | 8.37 | 9.13 | 0.509 |
Net Income Before Extraordinary Items | |||||
Net Income | 1.54 | 6.35 | 8.37 | 9.13 | 0.509 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 1.54 | 6.35 | 8.37 | 9.13 | 0.509 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.03 | 0.127 | 0.162 | 0.176 | 0.012 |